By the close of trading Wednesday, Medline stock had risen 41.3% from its IPO price to $41. PitchBook analysts say private ...

Dow Jones Top Markets Headlines at 9 PM ET: AI-Themed Stocks Take More Hits, Sending Nasdaq Lower | Fed's ... Tech shares weighed on indexes; Oracle, Nvidia and Tesla dropped more than 3%. Fed's ...

Dow Jones Top Company Headlines at 9 PM ET: Elliott Builds Over $1 Billion Stake in Lululemon | BP ... The activist investor is pushing for former Ralph Lauren executive Jane Nielsen to be Lululemon's ...

Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation ; $347.00: Mrd: Ntybtrgl: Micron Is Benefitting From Immense Pricing and AI Demand, but Remains Cyclical ...

Venezuela accounts for a small part of the global oil supply, producing about 1 million barrels per day, or just under 1%.

More recently, OCI’s strong client focus and ability to scale put it squarely at the center of the booming AI ecosystem, leading to skyrocketing bookings with key AI stakeholders such as OpenAI, Meta, ...

While Micron shares are up 168% so far this year, they fell for five straight sessions in the leadup to Wednesday's report, as investors have come to worry about the health of the AI trade thanks to ...

Fitch's downgrade follows Vanke's entry into a grace period of five working days for the repayment of principal and interest on the onshore bond, the rating company said, adding that Vanke expects to ...

Dow Jones Top Company Headlines at 7 PM ET: BP Turns to Outsider as Next CEO | Micron ... Meg O'Neill is resigning from her role leading Woodside Energy to become BP's CEO. Micron Logs Sales Jump, ...

The move - via the launch of a grocery-shopping app within the popular AI chatbot - makes DoorDash (DASH) the latest company to provide AI-driven purchases. And it comes ahead of plans by the company ...

Kelsian is one of the biggest operators of metropolitan bus services for state governments throughout Australia. It also runs private-sector transportation services for Australian resource companies ...

Johnson & Johnson's Rybrevant Faspro was approved as a treatment for people with lung cancer by the Food and Drug Administration. Rybrevant Faspro was approved across all indications for subcutaneous ...